Assessment of potential substance abuse treatment medications in nonhuman primate models.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N95024C00004
- Awardee
-
The Mclean Hospital Corporation UEI MCKWJYCWNVN3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,692,445
Award facts
- Opportunity
-
- Assessment of potential substance abuse treatment medications in nonhuman primate models Pre-Solicitation · 75N95023R00047 · Posted Mar 29, 2023
- Contract value 100% obligated
- $2,692,445.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Belmont, MA 02478, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$387,107 | |
| Exercise an Option | $1,579,653 | |
| Original award | $1,499,899 |
About this award
This federal contract award, valued at $2,692,445.32, was granted by the National Institute on Drug Abuse (NIDA) to The Mclean Hospital Corporation, a non-profit psychiatric teaching hospital affiliated with Harvard Medical School. The contract, which has a period of performance ending on December 15, 2025, is for the "Assessment of Potential Substance Abuse Treatment Medications in Nonhuman Primate Models."
The original solicitation was a sources sought notice to identify qualified small businesses capable of providing non-human primate models to evaluate potential substance abuse treatment medications. The contract will support NIDA's research portfolio in developing new therapeutic agents to diminish the reinforcing effects of drugs of abuse, curtail subjective effects, decrease addictive properties, and reduce withdrawal symptoms. The award is a definitive contract with a cost-no-fee pricing type and does not have a set-aside designation.
Quick answers
Who was awarded contract 75N95024C00004?
75N95024C00004 was awarded to The Mclean Hospital Corporation by National Institute on Drug Abuse (National Institutes of Health) on December 16, 2023.
How much is contract 75N95024C00004 worth?
The government has obligated $2,692,445 on 75N95024C00004.
Was contract 75N95024C00004 competed?
The extent of competition for 75N95024C00004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award